Drug Profile
Research programme: 5T4-based companion diagnostic - Pfizer
Alternative Names: 5T4-based diagnostic - PfizerLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Oxford BioMedica; Pfizer
- Class Monoclonal antibody diagnostics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer(Diagnosis) in USA
- 04 May 2011 Early research in Cancer (diagnosis of 5T4 positive disease) in USA (unspecified route)